Patient Home Monitoring (PHM) Announces Results of Annual and Special Shareholder Meeting, Approval of Continuance From Alberta to British Columbia and Adoption of Advance Notice Provisions

SAN FRANCISCO, CALIFORNIA--(Marketwired - Dec. 9, 2013) - Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on rolling-up annuity-based healthcare service companies in the US and Canada, today held an annual and special meeting of shareholders with several resolutions designed to support corporate efficiency in executing its acquisition strategy.

PHM is addressing a large and fragmented market of small, profitable businesses providing healthcare products and services to chronically ill patients. PHM plans to acquire these businesses and then offer additional services to its entire patient base, thereby increasing revenue per patient and achieving organic post acquisition growth.

PHM announced that, in addition to the other matters put forward to the shareholders of PHM at the annual and special meeting of shareholders held today December 9, 2013, the shareholders approved the proposed continuance of PHM from the Province of Alberta to the Province of British Columbia (the "Continuance"). Further details of the Continuance are set out in the Corporation's Management Information Circular dated November 7, 2013 filed under the Corporation's profile on SEDAR at www.sedar.com.

In approving the Continuance, the shareholders of the Company also approved the articles to be adopted upon the completion of the Continuance which will include advance notice provisions (the "Advance Notice Provisions") requiring that advance notice be provided to the Company in circumstances where nominations of persons for election to the board of directors of PHM (the "Board") are made by shareholders of the Company other than pursuant to: (i) a requisition of a meeting of shareholders made pursuant to the provisions of the Business Corporations Act (British Columbia)(the "BC Act"); or (ii) a shareholder proposal made pursuant to the provisions of the BC Act. The purpose of the Advance Notice Provisions is to foster a variety of interests of the shareholders and the Company by ensuring that all shareholders - including those participating in a meeting by proxy rather than in person -receive adequate notice of the nominations to be considered at a meeting and can thereby exercise their voting rights in an informed manner. In addition, the Advance Notice Provisions should assist in facilitating an orderly and efficient meeting process. The Advance Notice Provisions provide shareholders, directors and management of the Company with a clear framework for nominating directors. Among other things, the Advance Notice Provisions fix a deadline by which holders of common shares must submit director nominations to the Company prior to any annual or special meeting of shareholders and sets forth the minimum information that a shareholder must include in the notice to the Company for the notice to be in proper written form.

In the case of an annual meeting of shareholders, notice to the Company must be made not less than 30 nor more than 65 days prior to the date of the annual meeting; provided, however, that in the event the annual meeting is to be held on a date that is less than 40 days after the date on which the first public announcement of the date of the annual meeting was made, notice may be made not later than the close of business on the 10^th day following such public announcement.

In the case of a special meeting of shareholders (which is not also an annual meeting), notice to the Company must be made not later than the close of business on the 15^th day following the day on which the first public announcement of the date of the special meeting was made.

A copy of the articles containing the full text of the Advance Notice Provisions will be available under the Company's profile on SEDAR at www.sedar.com following the completion of the Continuance.

All resolutions were approved including reappointment of auditor, re-election of the Directors, approval of the Chief Executive options grant and updating the stock option plan.

About PHM

The explosive growth in the number of elderly patients in the US healthcare market is creating pressure to provide more efficient delivery systems. Healthcare providers, such as hospitals, physicians and pharmacies, are seeking partners that can offer a range of products and services that improve outcomes, reduce hospital readmissions, and help control costs. PHM fills this need by delivering a growing number of specialized products and services to achieve these goals.

PHM is currently a positive cash flow and profitable company servicing patients with chronic heart disease and will act as a platform for acquisitions. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively working to identify and evaluate profitable, annuity-based companies to acquire their patient databases and technical expertise at favorable prices. PHM's post acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.